Objectives: We conducted propensity score matching to determine whether the use of the right internal thoracic artery (RITA) confers a survival advantage when compared with the radial artery (RA) as second arterial conduit in coronary artery bypass grafting.
Methods:
The study population included a highly selected low-risk group of patients who received the RITA (n ¼ 764) or the RA (n ¼ 1990) as second arterial conduit. We obtained 764 matched pairs that were comparable for all pretreatment variables. A time-segmented Cox regression model that stratified on the matched pairs was used to investigate the effect of treatment on late mortality.
Results: After a mean follow-up of 10.2 AE 4.5 years (maximum 17.3 years), survival probabilities at 5, 10, and 15 years were 96.4% AE 0.7% versus 95.4% AE 0.7%, 91.0% AE 1.1% versus 89.1% AE 1.2%, and 82.4% AE 1.9% versus 77.2% AE 2.5% in the RITA and RA groups, respectively. During the first 4 years, RITA and RA were comparable in terms of mortality (hazard ratio [HR], 1.00; 95% confidence interval [CI] , 0.56-1.78; P ¼ .98). However, after 4 years RITA was associated with a significant reduction in late mortality (HR, 0.67; 95% CI, 0.48-0.95; P ¼ .02). RITA was superior to RA when the experimental conduit was used to graft the left coronary system (HR, 0.69; 95% CI, 0.47-0.99; P ¼ .04) but not the right coronary system (HR, 0.98; 95% CI, 0.59-1.62; P ¼ .93).
Conclusions:
In a highly selected low-risk group of patients, the use of the RITA as second arterial conduit instead of the RA was associated with better survival when used to graft the left but not the right coronary artery. (J Thorac Cardiovasc Surg 2017;153:79-88)
Kaplan-Meier survival curve probabilities in the right internal thoracic artery (RITA) and the radial artery (RA) groups in the propensity-score-matched population.
Central Message
In a highly selected low-risk group of patients, the use of the RITA as second arterial conduit instead of the RA was associated with better survival when used to graft the left but not the right coronary artery.
Perspective
The choice of the right internal thoracic artery (RITA) or radial artery (RA) as the second conduit in patients undergoing CABG remains controversial. In a highly selected low-risk group of patients, the use of the RITA as second arterial conduit instead of the RA was associated with better survival when used to graft the left but not the right coronary artery.
See Editorial Commentary page 89.
Despite increasing recognition that multiple arterial conduits improve long-term outcomes after coronary artery bypass grafting (CABG), 1 the quest for the second-best arterial conduit to supplement the left internal thoracic artery (LITA) continues. 2 In particular, it is still to be determined whether the use of the right internal thoracic artery (RITA) confers a survival advantage when compared with the radial artery (RA). 3 To date, only a single randomized controlled trial (RCT) 3 has been published in the literature, largely underpowered to detect any difference in long-term survival between the RITA and RA groups. Several observational studies comparing RITA with RA have been reported with conflicting findings. [4] [5] [6] [7] [8] [9] [10] [11] [12] Propensity score matching (PSM)-based analysis of observational data is emerging as an attractive alternative in view of the paucity of evidence from RCT, and can be relied upon as evidence when RCTs are not possible. 4 Recently, general recommendations have been proposed for conducting PSM. [13] [14] [15] We aimed to compare shortterm outcomes and long-term survival in patients receiving RITA versus RA as second arterial conduit by conducting a single-center 15-year outcomes PSM comparison in accordance with current recommendations.
METHODS
The study was conducted in accordance with the principles of the Declaration of Helsinki. The local audit committee approved the study, and the requirement for individual patient consent was waived. We retrospectively analyzed prospectively collected data from The National Institute for Cardiovascular Outcomes Research (NICOR) NACSA registry on June 1, 2015, for all isolated first-time CABG procedures performed at the Bristol Heart Institute, Bristol, United Kingdom, from April 1996 to April 2015. Reproducible cleaning algorithms were applied to the database, which are regularly updated as required. Briefly, duplicate records and nonadult cardiac surgery entries were removed; transcriptional discrepancies harmonized; and clinical conflicts and extreme values corrected or removed. The data are returned regularly to the local units for validation.
Further details and definition of variables are available at http://www. ucl.ac.uk/nicor/audits/adultcardiac/datasets. Of 15,119 isolated first-time cases of CABG performed during the study period, we selected patients who met the following criteria: multivessel coronary disease including left main and/or left anterior descending artery (LAD) coronary disease; requiring at least 2 grafts; CABG performed using the following strategies: LITA used in situ to graft the LAD territory and RA to graft the non-LAD territory with or without additional saphenous vein (SV) grafts (RA group) or both LITA and RITA with or without additional SV grafts as required in both groups ( Figure E1 ). Patients receiving both the RITA and the RA (n ¼ 275) were excluded from the present analysis. In the present series, the RITA and the RA were used only in cases where target stenosis was !75%. The RA was used as a free graft directly connected to the ascending aorta. The internal thoracic artery was harvested as a pedicle in all cases and was used as an in situ graft that remained proximally connected to its respective subclavian artery or as a free graft proximally connected to other internal thoracic artery.
Pretreatment Variables and Study Endpoints
The effect of adding the RA as a third arterial conduit instead of SV was adjusted for the following variables: age, gender, body mass index (BMI); previous myocardial infarction, previous percutaneous coronary intervention (PCI); diabetes mellitus orally treated or on insulin; chronic obstructive pulmonary disease (COPD); current smoking; serum creatinine !200 mmol/L, previous cerebrovascular accident (CVA); peripheral vascular disease; preoperative atrial fibrillation; left main disease; non-LAD vessel diseased including diagonal; circumflex artery (CX); right coronary artery (RCA); left ventricle ejection fraction, non-elective priority, off-pump coronary artery bypass (OPCAB), procedure performed by resident versus attending surgeon and logistic euroSCORE.
Short-term endpoints were 30-day mortality, need for postoperative intraaortic balloon pump (IABP), re-exploration for bleeding, renal replacement therapy, and sternal wound reconstruction. Long-term end-point was all-cause mortality, which is a robust and unbiased index for comparative studies because no adjudication is required. 16 Information about death was obtained from the institutional database and the National General Register Office for all patients. Follow-up was completed for all patients (100%).
Statistical Analysis
For baseline characteristics, variables are summarized as mean for continuous variables and proportion for categorical variables. Multiple imputation was used to address missing data (Table E1 and Figure E2 ) (available from: http://www.jstatsoft.org/v45/i07/). To control for measured potential confounders in the data set, a propensity score (PS) was generated for each patient from a multivariable logistic regression model based on pretreatment covariates as independent variables, with treatment type (RITA vs RA) as a binary dependent variable according to current recommendations. 13, 15 The resulting propensity score represented the probability of a patient receiving the RITA as second arterial conduit. Because the PS model achieved a good discriminatory power (C-statistic ¼ 0.74; Figure E3 ), no attempt was made to include interactions or nonlinear terms. Pairs of patients receiving RITA and RA were derived using greedy 1:1 matching with a caliper of width of 0.2 standard deviation of the logit of the PS 14 (available from: http://CRAN.Rproject.org/ package¼nonrandom). The quality of the match was assessed by comparing selected pretreatment variables in propensity-score-matched patients using the standardized mean difference (SMD), by which an absolute standardized difference of greater than 10% is suggested to represent meaningful covariate imbalance. [13] [14] [15] Analytic methods for the estimation of the treatment effect in the matched sample were selected. McNemar's test was used to compare postoperative complication rates in the 2 groups. 13 In the primary Kaplan-Meier analysis, comparing late survival between the 2 groups, it was found that the curves crossed thus showing that the proportional hazards assumption was violated and the hazard was not constant with time. To evaluate the trends in this Kaplan-Meier curve, time-segmented Cox regression models before and after the curves crossed, 17 stratified on the matched pairs, 18 were used to investigate the effect of treatment (RITA vs RA) on early and late mortality phases. This approach accounts for the within-pair homogeneity by allowing the baseline hazard function to vary across matched sets (available from: http:// CRAN.R-project.org/package¼survival). The Schoenfeld residuals test was used to confirm the nonviolation of the proportional hazard assumption in the 2 separate Cox models. Subgroup analysis on late mortality according to the experimental conduit target, RITA configuration, and OPCAB use was carried out by mains of covariate adjustment using the PS on the overall sample to account for the relatively small sample size. Finally, because of the different distribution in OPCAB rate across the years ( Figure E4 ), the treatment effect was adjusted for the interaction between OPCAB and year of surgery. Because of the highly selected low-risk population, frailty models were not used. All P values less than .05 were considered to indicate statistical significance. All statistical analysis was performed using R statistical software (version 3.2.3; R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
The study population included 764 low-risk patients who received RITA with (n ¼ 482) or without (282) additional SV grafts and 1990 patients who received the RA with (n ¼ 1206) or without (784) additional SV grafts. The distribution of patient characteristics before and after PS matching is summarized in Table 1 . In the unmatched group, RA tended to present a higher burden of comorbidities. In particular they were more likely to be older and female and to have a BMI ! 30, COPD, and diabetes (both orally treated and on insulin) and impaired left ventricular function. OPCAB rate was higher in the RA group (Video 1). After matching the 764 matched pairs, the groups were comparable for all pretreatment variables (SMD < 10, Figure 1 ).
Arterial Graft Configuration
The mean number of grafts performed was 2.87 AE 0.76 in the RITA group versus 2.80 AE 0.70 and 2.87 AE 0.70 in the unmatched (P ¼ .003) and matched (P ¼ .1) RA groups, respectively. Graft targets in the unmatched and matched groups are summarized in Table 2 . The RITA was used to graft the CX territory in 319 (42%) cases, the RCA territory in 245 (32%) cases, and the LAD territory in 200 (26%) RITA, Right internal thoracic artery; RA, radial artery; PSM, propensity score matching; SMD, standardized mean difference; SD, standard deviation; BMI, body mass index; MI, myocardial infarction; PCI, percutaneous coronary intervention; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral vascular disease; AF, atrial fibrillation; LVEF, left ventricular ejection fraction; IABP, intra-aortic balloon pump; OPCAB, off-pump coronary artery bypass grafting; LMS, left main stem; LAD, left anterior descending artery; RCA, right coronary artery; CX, circumflex artery; DIA, diagonal.
cases. Overall, the CX territory was grafted using an internal thoracic artery in 519 (68%) cases. The RA was used to graft the CX territory in 1530 (77%) cases and 565 (74%) cases, the RCA territory in 460 (23%) cases and 199 (26%) cases in the unmatched and matched RA groups, respectively. The RITA was used as a Y-graft in 144 cases and as in situ graft in the remaining 620 cases.
Short-Term Outcomes
Short-term outcomes in the matched samples are summarized in Table 3 . The 2 groups were comparable in terms of 30-day mortality, incidence of CVA, and need for renal replacement therapy. However, we found a trend towards a higher rate of re-exploration for bleeding, sternal wound reconstruction, and need for postoperative IABP in the RITA group, although the overall incidence of these complications was relatively low. Hospital stay length tended to be increased in the RITA group. Short-term outcomes in the unmatched RA group are reported in Table E2 .
Mortality
In the PS-matched group, mean time to follow-up was 10.2 AE 4.5 years (maximum 17.3 years) and 10.1 AE 5.1 and 10.3 AE 3.7 years in the RITA and matched RA groups, respectively (P ¼ .31). A total of 85 and 106 deaths were recorded in the RITA and RA groups, respectively. Survival probabilities at 5, 10, and 15 years were 96.4% AE 0.7% versus 95.4% AE 0.7%, 91.0% AE 1.1% versus 89.1% AE 1.2%, and 82.4% AE 1.9% versus 77.2% AE 2.5% in the RITA and RA groups respectively. The 2 survival curves crossed at 4 years (96.9 AE 0.6 years, Figure 2 ). During the first 4 years, RITA and RA were VIDEO 1. Radial artery grated to the circumflex artery during off-pump coronary artery bypass. Video available at: http://www.jtcvsonline.org/ article/S0022-5223(16)31099-6/addons. FIGURE 1. Graphic visualization of standardized mean difference before after propensity score matching. RCA, Right coronary artery; LAD, left anterior descending artery; LMD, left main disease; PVD, peripheral vascular disease; CX, circumflex artery; PCI, percutaneous coronary intervention; IABP, intraaortic balloon pump; DIA, diagonal; MI, myocardial infarction; CVA, cerebrovascular accident; AF, atrial fibrillation; LV, left ventricle; COPD, chronic obstructive pulmonary disease; BMI, body mass index; DM, diabetes mellitus; OPCAB, off-pump coronary artery bypass grafting. Figure E5 ). The survival rates in the unmatched RA group are reported in Figure E6 . Subgroup analysis on late mortality (after 4 years). Subgroup analysis suggested that the RITA was superior to the RA in term of late survival when the experimental conduit was used to graft the left coronary system (HR, 0.69; 95% CI, 0.47-0.99; P ¼ .04), but not the right coronary system (HR, 0.98; 95% CI, 0.59-1.62; P ¼ .93) (Figure 3 ). In cases with the experimental conduit grafted on the right coronary system only, neither in situ RITA (HR, 0.76; 95% CI, 0.42-1.36; P ¼ .1) nor free RITA (HR, 1.78; 95% CI, 0.89-3.56; P ¼ .3) were significantly associated with a better late survival when compared with the RA (Figure E7 ).
On the other hand, in cases with the experimental conduit grafted on the left coronary system only, we could not demonstrate any significant difference between free RITA over in situ RITA (HR, 0.55; 95% CI, 0.21-1.43; P ¼ .22; Figure 4 ). No significant difference in late mortality could be demonstrated between the RITA grafted to the CX (with LITA to LAD) when compared with the RITA grafted to the LAD territory (with LITA to CX) (HR, 0.71; 95% CI, 0.34-1.43; P ¼ .33). When patients receiving sequential grafts were excluded, the use of RITA to graft the left coronary system was still found to be superior to the RA (HR, 0.65; 95% CI, 0.43-0.99; P ¼ .04). Finally the protective effect of RITA over RA on late mortality was confirmed when adjusted for the interaction between RITA, Right internal thoracic artery; RA, radial artery; RCA, right coronary artery; CX, circumflex artery; LAD, left anterior descending artery. *LITA was used to graft the LAD as an in situ graft. yRITA proximally connected to the LITA (Y-graft). zLITA was used to graft the CX as an in situ graft. RITA, Right internal thoracic artery; PSM, propensity score matching; RA, radial artery; CVA, cerebrovascular accident; RRT, renal replacement therapy; IABP, intraaortic balloon pump; SW, sternal wound; SD, standard deviation. OPCAB and era of surgery (HR, 0.73; 95% CI, 0.54-0.99; P ¼ .04).
DISCUSSION
The present single-center long-term PSM analysis showed that, in a low-risk population, the use of the RITA when compared with the RA as second arterial conduit was associated with superior long-term survival in patients undergoing CABG. The trend towards a survival benefit from the RITA was evident only after 4 years from the index operation. We found that the RITA was associated with improved late survival only when the experimental conduit was used to graft the left coronary system. When used to graft the left coronary system, free RITA and in situ RITA showed comparable long-term survival. Survival after RITA to LAD graft did not significantly differ from RITA to CX graft.
The use of the RITA over the RA did not significantly increase operative mortality (within 30 days), the incidence of postoperative CVA, or the need for renal replacement therapy. However, we found a trend towards an increased incidence of re-exploration for bleeding, IABP requirement, sternal wound complication requiring reconstruction, and prolonged hospital stay length in patients receiving the RITA. However, the overall incidence of these complications was particularly low, partially due to the low-risk profile of the study population.
Despite the slow initial adoption, multiple arterial grafting is now widely advocated by the cardiovascular community. 1 The use of both RITA and RA has been shown to be associated with better long-term survival when compared with the traditional strategy using a single internal thoracic artery and additional SV grafts. 9 Controversy still remains on whether the use of the RA as a second arterial conduit achieves the same long-term benefits as that documented with the use of the RITA. [5] [6] [7] [8] [9] [10] [11] [12] The lack of clear evidence, the potentially increased sternal wound complication rate, and the perceived technical complexity when using bilateral internal thoracic arteries often results in the RA as the preferred second conduit of choice. 1 The only randomized direct comparison in the literature is the Radial Artery Patency and Clinical Outcome, 3 which randomized 196 patients to receive the RITA grafts and 193 patients to receive the RA grafts. No significant differences in terms of angiographic patency or clinical outcome were found at midterm follow-up. However, the trial was largely underpowered to detect significant differences in survival between the 2 groups.
PSM is emerging as an attractive alternative in view of the paucity of evidence from RCT. 4 Recently, conflicting results on the superiority of the RITA over the RA have been reported by several PSM studies. Schwann and colleagues 9 reported on 551 propensity-matched RITA and RA, and their conclusions supported the equipoise between RITA and RA as the second-best arterial conduit. However, it should be noted that their analysis showed a clear trend towards a better survival by using RITA over RA (HR, 1.35; 95% CI, 0.98-1.81). Shi and colleagues 10 performed a PSM on 318 matched pairs of patients receiving RITA versus RA. They demonstrated a marginally significant survival benefit from RITA (HR, 0.78; 95% CI, 0.60-1.00; P ¼ .048). On the contrary, Tranbaugh and colleagues 11 reported on 528 pairs who received either a RA or a free RITA to bypass the circumflex coronary. Ten-year survival was 85% for patients receiving RA and 80% for patients receiving RITA, which was not statistically significant (P ¼ .06). RA patency (83.9%) was similar to RITA patency (87.4%) (P ¼ .15). It should be noted that, in their series, Tranbaugh and colleagues used the RITA as free graft directly connected to the aorta in 42% of cases, and the caliper mismatch between the aorta and the RITA might have affected its patency thus neutralizing its superior patency.
By conducting a single-center 15-year PSM on 764 pairs of patients receiving the RITA versus the RA as the second arterial conduit, we found that the use of the RITA is associated with a significant risk reduction of mortality after 4 years, but that this benefit is more likely to be relevant only when the RITA is used to graft the left coronary system. These findings are supported by previous studies that suggested that, for bilateral ITA grafting to improve long-term outcomes over single ITA-to-LAD grafting, the second ITA should bypass the CX rather than the RCA. [19] [20] [21] Schmidt and colleagues 19 observed a long-term survival of 93% when both ITAs were used to bypass left-sided coronary arteries, but only 70% when grafted to the RCA system after a mean follow-up of 9.2 years (P ¼ .02). Carrel and colleagues 20 and Pick and colleagues 21 have separately reported that using both ITAs to graft left-sided coronaries may increase survival over single ITA revascularization. These observations may reflect the lower patency of ITA grafts when used to bypass the RCA system compared with left-sided coronary arteries. Grafts to the 3 different coronary artery territories have different patency rates that have been clearly demonstrated for individual ITA grafts. 22 Robinson and colleagues 23 recently reported on postdischarge angiography of 296 free RITA as Y-grafts, including a total of 1174 individual anastomoses: there were 428 anterior wall (36.5%), 411 lateral wall (35.0%), and 335 inferior wall (28.5%) anastomoses. The patency rates for these were 90.6%, 83.9%, and 62.3%, respectively.
In contrast, Kurlansky and colleagues 24 compared 1479 RITA used to revascularize the left coronary system with 736 RITA used to graft the right coronary system, and they found similar survival after a mean follow-up of 12 years. In their series, in situ grafting was used in most of the cases (approximately 98% of arteries grafted) and, when using the RITA to the RCA, efforts were made to graft severely stenosed vessels and distal branches rather than the main RCA. In this context, Sabik at al. 25 were able to document equivalent long-term results with the use of the RITA, whether applied to the left or right coronary system. Their findings of similar survival whether the RITA was used to bypass the RCA or CX system were attributable to careful patient selection. In fact, 2 important factors used in selecting the RCA as the site for the RITA: (1) stenosis 70% to 90% with viable myocardium in its distribution; and (2) freedom from distal stenosis. They were, therefore, likely to graft a RCA with a RITA only when the likelihood of the RITA graft remaining patent, and thus effectiveness was high.
We could not demonstrate a superiority of in situ over Ygraft RITA configuration when the RITA was used to graft the left coronary system. This result is supported by a recent study by Hwang and colleagues 26 on 398 patients who underwent OPCAB with in situ RITA (n ¼ 164) graft or free RITA y-composite graft (n ¼ 234) used to graft the left coronary system. They found that the 5-year patency rate was 92.5% versus 92.4% for in situ RITA and free RITA grafts, respectively (P ¼ .97). Finally, we found that in situ RITA to LAD was a valid alternative to in situ LITA to LAD when performing CABG using bilateral ITAs grafting on the left coronary system being associated with similar survival rates. The RITA to LAD strategy represents an easily reproducible and technically less-demanding strategy compared with other configurations. The RITA is biologically identical to the LITA, and excellent angiographic results have been reported for RITA to LAD grafts. 22 Tatoulis and colleagues 22 reported a 95% 10-year patency rate for 149 RITA to LAD grafts, and this result was comparable with LITA to LAD grafts (96%). In a previous series, we demonstrated a similar survival rate and freedom from reintervention between RITA to LAD versus LITA to LAD in the context of bilateral ITA grafting. 27 Although in this low-risk population, operative morbidity and mortality was particularly low in both groups, we found that the use of RITA was associated with an increased risk of re-exploration for bleeding, need for IABP, sternal wound reconstruction, and prolonged hospital stay length. Inability Acquired: Coronaryto control bleeding from branches of the retrocaval and retroaortic routed RITA, which are in spasm at the time of closure and bleed later because of vasodilatation, as well as an increased number of potential bleeding sites due to construction of the Y-graft, are some of the plausible reasons for the higher rate of re-exploration in the RITA group. 28 Moreover, retrocaval and transverse sinus routing of the RITA might compromise graft flow because of undetected kinks, graft overstretching, or rotation, which can partially account for the increased need for IABP. 28 Finally, the use of RITA was confirmed to increase the risk of sternal wound reconstruction. In the present series, a pedicled harvesting technique was used in all cases and this might account for this result and better results are anticipated by using a skeletonized technique. 29 Taking into account the observed increased complications rate associated with the RITA, and based on the observation that the beneficial effect on survival from the RITA may be delayed by as much as 7 to 10 years, 30 it seems reasonable to consider the RA as a valid option in older patients or patients with a greater number of risk factors such as diabetes and obesity. 31 The present analysis has intrinsic limitations. The main limitation of our study is that no follow-up data were available to compare the groups with respect to the cause of death (cardiac vs noncardiac), recurrence of angina, need for repeated revascularization, or graft patency. Therefore, we can only speculate that the mechanism beyond the better long-term survival observed in our RITA group is related to the better patency rate of the RITA over the RA. Propensity technique can adjust only for measurable and included variables and we cannot exclude a selection bias based on non-measurable ''eye-ball'' variables (with the RITA reserved to healthier and better patients).
In conclusion, we found that in a highly selected low-risk group of patients, the use of the RITA as a second arterial conduit instead of the RA, was associated with better survival when used to graft the left but not the RCA. This gain in long-term survival may be at the expense of short-term morbidity. MI, Myocardial infarction; PCI, percutaneous coronary intervention; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral vascular disease; AF, atrial fibrillation; LMS, left main stem; LVEF, left ventricular ejection fraction; IABP, intra-aortic balloon pump; OPCAB, off-pump coronary artery bypass grafting; BMI, body mass index; LAD, left anterior descending artery; DIA, diagonal; CX, circumflex artery; RCA, right coronary artery.
